1. Home
  2. ONC vs WBD Comparison

ONC vs WBD Comparison

Compare ONC & WBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • WBD
  • Stock Information
  • Founded
  • ONC 2010
  • WBD 1923
  • Country
  • ONC Switzerland
  • WBD United States
  • Employees
  • ONC N/A
  • WBD N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • WBD Cable & Other Pay Television Services
  • Sector
  • ONC Health Care
  • WBD Telecommunications
  • Exchange
  • ONC Nasdaq
  • WBD Nasdaq
  • Market Cap
  • ONC 37.3B
  • WBD 31.8B
  • IPO Year
  • ONC N/A
  • WBD N/A
  • Fundamental
  • Price
  • ONC $330.57
  • WBD $19.10
  • Analyst Decision
  • ONC Strong Buy
  • WBD Buy
  • Analyst Count
  • ONC 9
  • WBD 19
  • Target Price
  • ONC $335.78
  • WBD $13.32
  • AVG Volume (30 Days)
  • ONC 365.5K
  • WBD 73.0M
  • Earning Date
  • ONC 11-11-2025
  • WBD 11-06-2025
  • Dividend Yield
  • ONC N/A
  • WBD N/A
  • EPS Growth
  • ONC N/A
  • WBD N/A
  • EPS
  • ONC N/A
  • WBD 0.31
  • Revenue
  • ONC $4,562,002,000.00
  • WBD $38,441,000,000.00
  • Revenue This Year
  • ONC $875.58
  • WBD N/A
  • Revenue Next Year
  • ONC $20.99
  • WBD $0.43
  • P/E Ratio
  • ONC N/A
  • WBD $60.80
  • Revenue Growth
  • ONC 47.33
  • WBD N/A
  • 52 Week Low
  • ONC $170.99
  • WBD $7.08
  • 52 Week High
  • ONC $351.27
  • WBD $19.33
  • Technical
  • Relative Strength Index (RSI)
  • ONC 55.24
  • WBD 87.05
  • Support Level
  • ONC $324.03
  • WBD $12.00
  • Resistance Level
  • ONC $336.80
  • WBD $12.03
  • Average True Range (ATR)
  • ONC 7.92
  • WBD 0.90
  • MACD
  • ONC -0.43
  • WBD 0.79
  • Stochastic Oscillator
  • ONC 64.85
  • WBD 93.29

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

About WBD Warner Bros. Discovery Inc. Series A

Warner Bros. Discovery was formed in 2022 through the combination of WarnerMedia and Discovery Communications. It operates in three global business segments: studios, networks, and direct-to-consumer. Warner Bros. Pictures is the crown jewel of the studios business, producing, distributing, and licensing movies and television shows. The networks business consists of basic cable networks, such as CNN, TNT, TBS, Discovery, HGTV, and the Food Network. Direct-to-consumer includes HBO and the firm's streaming platforms, which have now been consolidated to Max and Discovery+. Much of the DTC content is created within the firm's other two business segments. Each segment operates with a global reach, with Max available in over 70 countries.

Share on Social Networks: